Public health must be the leading priority of Europe’s pharmaceutical sector

Public health must be the leading priority of Europe’s pharmaceutical sector

The EU must ensure access to affordable and quality medicines in Europe whilst guaranteeing everyone’s right to a healthy and sustainable environment. Human medicine is not an ordinary commodity – public interest and public health should prevail as leading...
What lies ahead for health under the German Presidency?

What lies ahead for health under the German Presidency?

Germany assumed the Presidency of the Council of the European Union from 1 July, but in quite different circumstances from what was originally foreseen, with the response to tackling COVID-19, and its health, economic and social consequences being the defining issue...
Ensure equitable global access for treatments, vaccines and diagnostics resulting from the ACT Accelerator, over 70 organisations ask

Ensure equitable global access for treatments, vaccines and diagnostics resulting from the ACT Accelerator, over 70 organisations ask

Following the launch of the Access to COVID-19 Tools Accelerator (ACT-A) by the World Health Organization (WHO) to bring  governments and global health actors together in an ‘unprecedented and inclusive partnership’ to address some of the challenges linked with the...
Get involved !

Get involved !

Sign up here to receive our updates on European health policy and invitations to our events.

Subscribe now

You have Successfully Subscribed!